Search

everythinglearnresearchcommunity

for

Search:↓

SLE patients experience two patterns of non-inflammatory symptoms: intermittent and persistent.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

The mtDNA N haplogroup is linked to a higher risk of late-onset lupus and specific symptoms in Han Chinese women.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

Certain proteins involved in DNA modification may affect the genetic changes in systemic lupus erythematosus and could indicate the disease's activity.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Diagnosing both systemic lupus and hemoglobinopathy is challenging due to overlapping symptoms.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Most lupus patients in the study experienced hair loss, which greatly affected their mental and social well-being.

Selenium supplements can help improve symptoms and metabolic markers in lupus patients.

A woman with lupus had rare severe symptoms but improved with treatment.

Many patients with cutaneous lupus erythematosus experience hair loss and nail problems, which are important for diagnosis and treatment.

Early identification of lupus through skin signs and blood tests is crucial in India.

Hydroxychloroquine may help COVID-19 patients with lupus.

Patients with lupus nephritis and COVID-19 can improve with proper treatment.

Most pregnancies with SLE resulted in intrauterine growth restriction (IUGR).

A TNFAIP3 gene mutation can cause unusual and varied symptoms of lupus and Sjogren's syndrome.

Patients with Discoid Lupus Erythematosus have lower vitamin D and antioxidant levels and higher oxidative stress.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

New tools and criteria have been developed to better assess and treat pediatric lupus.

42% of SLE patients had thyroid issues, mostly hypothyroidism.

Anifrolumab improves quality of life and reduces steroid use in lupus patients.

Non-scarring hair loss in lupus patients often responds well to treatment and doesn't lead to scarring.